FDA Inspection 1080790 — Carter BloodCare at Garland

Carter BloodCare at Garland — FEI 1641736

The FDA completed an inspection of Carter BloodCare at Garland on February 6, 2019 in Garland, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 6, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Garland, TX (United States)